About Chrysalis Biotherapeutics
Chrysalis Biotherapeutics is a private company based in Galveston, Texas. It has reported $515,000 raised in one offering on Form D since March 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 28, 2023 | Mar 22, 2024 | $515,000of $3.0M target | 12 | $42,917 | Equity, DebtRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Chrysalis Biotherapeutics's Form D filed Mar 22, 2024.
LS
Lauri Sower
Executive officer
DC
Darrell Carney
President and director
TS
Timothy Schmidt
Director
JR
James Ryaby
Director
MR
Marie Robb
Director
JS
Jeffery Sheldon
Director